Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Asporelix 0.25mg Injection

Prescription Icon
Prescription Required

Marketer

Bharat Serums & Vaccines Ltd

Salt Composition

Cetrorelix (0.25mg)

Overview Asporelix 0.25mg Injection

Gonadorelin antagonist Asporelix 0.25mg Injection aids female infertility treatment by suppressing premature egg release. Administered subcutaneously by a healthcare professional, self-injection is contraindicated. Home injection instruction may be provided by your doctor or nurse. Dosage frequency varies depending on individual needs and is determined by your physician to optimize treatment. Continue use as directed. Common side effects include injection site reactions (erythema, pruritus, irritation), nausea, and emesis. Rotate injection sites to minimize irritation. Seek immediate medical attention for dizziness, syncope, abdominal pain, or persistent vomiting. Prior to Asporelix initiation, disclose any pre-existing hepatic or renal conditions, and breastfeeding status. Inform your doctor of all concurrent medications, as interactions may affect Asporelix's efficacy.

Primary Ingredients of Asporelix 0.25mg Injection

The information is unavailable.

Uses of Asporelix 0.25mg Injection

Inability to conceive in women

Major Benefits of Asporelix 0.25mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Asporelix 0.25mg Injection:

  • Nausea
  • Ovarian hyperstimulation syndrome
  • Injection site reactions (pain, swelling, redness)
  • Itching
  • Irritation
  • Vomiting
  • Lower abdominal pain

How to use Asporelix 0.25mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Asporelix 0.25mg Injection works:

During infertility treatment in women, premature egg release may occur, yielding eggs unsuitable for fertilization. Asporelix 0.25mg Injection inhibits a naturally occurring hormone, thereby preventing this premature ovarian release of eggs.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Asporelix 0.25mg Injection concurrently with alcohol. Physician consultation is recommended.

PregnancyPregnancyUNSAFE

Administering Asporelix 0.25mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use, given that research in both animal models and pregnant humans has revealed considerable harm to the fetus.

Breast feedingBreast feedingUNSAFE

Administering Asporelix 0.25mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingSAFE

Driving ability is typically unaffected by Asporelix 0.25mg Injection.

KidneyKidneyCAUTION

Caution is advised when administering Asporelix 0.25mg Injection to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended. Asporelix 0.25mg Injection is contraindicated in patients exhibiting severe kidney disease.

LiverLiverCAUTION

Patients with hepatic impairment should use Asporelix 0.25mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Asporelix 0.25mg Injection :

Should you forget a dose of Asporelix 0.25mg Injection, seek your physician's advice.

Facts to Know About Asporelix 0.25mg Injection

LabelValue
Type of Compound Short chains of amino acids
Potential for Dependence None.
Type of Medication ENDOCRINE REGULATORS
Mechanism of Action GnRH receptor blockers

FAQs on Asporelix 0.25mg Injection

Ganirelix 0.25mg Injection, a parenteral formulation, contains ganirelix as its active component. This medication is administered to women participating in specific fertility programs. Its mechanism of action involves inhibiting luteinizing hormone (LH) secretion, thereby preventing premature egg release and allowing for optimal oocyte maturation. Concomitant use with other drugs is typical.
Administered intravenously, this medication is exclusively provided in a hospital or clinic setting by qualified medical personnel. Patients undergo routine monitoring to assess follicular growth. Treatment length is determined by individual ovarian response.
Skin redness, possibly with swelling, is the most frequently reported reaction at the injection site. Headache and nausea are also possible. These side effects are usually short-lived; however, persistent symptoms warrant a physician consultation. Furthermore, ovarian hyperstimulation syndrome (OHSS), multiple pregnancies, and birth defects have been linked to this medication.
Asporelix 0.25mg Injectio...
1,443
MRP 1,758
17% off